California Children's Services Program coverage of treatment for Central Precocious Puberty - Revised Policy on Palyniq (pegvaliase-pqpz) for Patients with Phenylketonuria- Revised Authorization of Sapropterin Dihydrochloride (Kuvan) - Revised Documentation Standards for the California Children's Services Medical Therapy Program Antisense Oligonucleotide Treatment of Duchene Muscular Dystrophyįibrosis Transmembrane Conductance Regulator Modulator Drug Therapies C alifornia Children's Services Program Whole Child Model (Revised December 2021) Sign up for e-mail notices (LISTSERV) when CMS Branch letters are posted. number and/or title you were trying to access, and we will forward to you a copy of the inactive N.L.Īdobe Acrobat Reader to view or print these documents. hyperlink displayed is not working, please send a request to, including the CCS N.L. that is no longer being displayed on this website, or the N.L. This includes ISCD removing all references to inactive and outdated N.L.s and only listing active N.L.s. CCS Numbered LettersĪs part of the Department of Health Care Services (DHCS) project to make all DHCS webpages compliant with the Americans with Disabilities Act (ADA), The Integrated Systems of Care Division (ISCD) is reorganizing this California Children's Services (CCS) Numbered Letter (N.L.) webpage.
0 kommentar(er)
